View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
WEDNESDAY, Nov. 24 (HealthDay News) -- Ischemic stroke patients treated with intravenous alteplase tend to fare better than those who do not undergo thrombolysis, and this holds true for those over the age of 80, according to research published online Nov. 23 in BMJ.
Nishant K. Mishra, of the University of Glasgow in the United Kingdom, and colleagues compared outcomes data on 23,334 subjects who underwent thrombolysis and 6,166 who did not to assess the impact age has on response to alteplase in acute ischemic stroke patients.
The researchers found that those who underwent thrombolysis had better functional outcome scores at 90 days than those who did not, and this association occurred independently in patients up to and older than 80 years of age.
"Outcome in patients with acute ischemic stroke is significantly better in those who undergo thrombolysis compared with those who do not. Increasing age is associated with poorer outcome but the association between thrombolysis treatment and improved outcome is maintained in very elderly people. Age alone should not be a barrier to treatment," the authors write.
Several authors disclosed financial relationships with pharmaceutical companies.
Editorial (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top